HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Cautious Approach To Bovine Tissue-Containing Supplements Urged By FDA

This article was originally published in The Tan Sheet

Executive Summary

Dietary supplement firms should take appropriate precautions to ensure the safety of supplement products that contain certain bovine tissue ingredients, FDA stresses in a Nov. 14 letter to industry.

You may also be interested in...



HHS Pick For FDA Commissioner Is Crawford; Bush Announcement Pending

HHS has recommended Virginia Tech Center for Food & Nutrition Policy Director Lester Crawford, PhD, to the White House as its choice for FDA commissioner.

FDA Bovine-Derived Supplement, BSE Actions Under Congressional Scrutiny

Two senior House Democrats seek FDA information on its efforts to track and control bovine-derived dietary supplement products that may be susceptible to potential BSE contamination in a Jan. 31 letter to Acting Commissioner Bernard Schwetz, PhD.

BioProgress Gelatin-Free Capsules Address Vegetarian, Ethical Concerns

BioProgress Technology International's XGel Film System, the first one-piece soft capsule technology containing a cellulose base instead of gelatin, has been licensed by Peter Black Healthcare, the leading supplier of private label vitamins, minerals and herbal supplements in the U.K.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS133343

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel